-
1
-
-
0038490209
-
-
Montvale, NJ: Medical Economics
-
Physician's desk reference. Montvale, NJ: Medical Economics, 1999.
-
(1999)
Physician's Desk Reference
-
-
-
2
-
-
0027201688
-
Seroquel: Electrophysiological profile of a potential atypical antipsychotic
-
Berl
-
Goldstein JM, Litwin LC, Sutton EB, et al. Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology (Berl) 1993; 112:293-298.
-
(1993)
Psychopharmacology
, vol.112
, pp. 293-298
-
-
Goldstein, J.M.1
Litwin, L.C.2
Sutton, E.B.3
-
3
-
-
0030795988
-
Multiple fixed doses of seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
-
Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997; 42:233-246.
-
(1997)
Biol Psychiatry
, vol.42
, pp. 233-246
-
-
Arvanitis, L.A.1
Miller, B.G.2
-
4
-
-
0030805337
-
A comparison of quetiapine and chloropromazine in the treatment of schizophrenia
-
Peuskens J, Link CG. A comparison of quetiapine and chloropromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997; 96:265-273.
-
(1997)
Acta Psychiatr Scand
, vol.96
, pp. 265-273
-
-
Peuskens, J.1
Link, C.G.2
-
5
-
-
0032994222
-
Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders
-
McManus DQ, Arvanitis LA, and Kowalcyr BB for the Seroquel Trial 48 Study Group. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 1999; 60:5:292-298.
-
(1999)
J Clin Psychiatry
, vol.60
, Issue.5
, pp. 292-298
-
-
McManus, D.Q.1
Arvanitis, L.A.2
Kowalcyr, B.B.3
-
6
-
-
0029878084
-
Group USSICI204, 636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia
-
Borison R, Arvanitis L, Miller B. Group USSICI204, 636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 1996; 16:158-169.
-
(1996)
J Clin Psychopharmacol
, vol.16
, pp. 158-169
-
-
Borison, R.1
Arvanitis, L.2
Miller, B.3
-
7
-
-
0030920294
-
Quetiapine in patients with schizophrenia: A high and low dose double-blind comparison with placebo
-
Small J, Hirsch S, Arvanitis L, et al. Quetiapine in patients with schizophrenia: a high and low dose double-blind comparison with placebo. Arch Gen Psychiatry 1997; 54:549-557.
-
(1997)
Arch Gen Psychiatry
, vol.54
, pp. 549-557
-
-
Small, J.1
Hirsch, S.2
Arvanitis, L.3
-
8
-
-
0000581521
-
Quetiapine (Seroquel); An effective and well tolerated atypical antipsychotic
-
Meats P. Quetiapine (Seroquel); an effective and well tolerated atypical antipsychotic. Int J Psychiatr Clin Pract 1997; 1:231-239.
-
(1997)
Int J Psychiatr Clin Pract
, vol.1
, pp. 231-239
-
-
Meats, P.1
-
10
-
-
0004171473
-
-
ADM 9-102, 9/85, Washington, DC: Public Health Administration, U.S. Department of Health and Human Services
-
Andreason N. Modified scale for the assessment of negative symptoms. NIMH treatment strategies in schizophrenia study. ADM 9-102, 9/85, Washington, DC: Public Health Administration, U.S. Department of Health and Human Services, 1985.
-
(1985)
Modified Scale for the Assessment of Negative Symptoms. NIMH Treatment Strategies in Schizophrenia Study
-
-
Andreason, N.1
|